Osteolysis and cancer.
Goltzman
D
D
Calcium Research Laboratory, Department of Medicine, McGill University Health Center, and Departments of Medicine and Physiology, McGill University, Montreal, Quebec Canada. david.goltzman@mcgill.ca
D001859:Bone Neoplasms / Q000473:pathology* / Q000628:therapy; D002352:Carrier Proteins; D006023:Glycoproteins / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins; D010010:Osteoclasts / Q000187:drug effects*; D010014:Osteolysis / Q000209:etiology* / Q000628:therapy; D053244:Osteoprotegerin; D011471:Prostatic Neoplasms / Q000556:secondary* / Q000628:therapy; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor
D002352:Carrier Proteins; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human